Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims Tetracaine Chlorhydrate, is a local anesthetic (ester type) presented as a sterile ophthalmic preparation for ocular use. It provides rapid, reversible anesthesia for diagnostic eye procedures, foreign body removal and minor ocular surgery. GNH USA supplies Minims Tetracaine Chlorhydrate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minims Tetracaine Chlorhydrate, a topical ophthalmic anesthetic, acts on peripheral nerve sodium channels to provide local anesthesia. - Diagnostic eye procedures: produces rapid anesthesia to facilitate examinations and imaging. - Foreign body removal: numbs the ocular surface to allow safe extraction of corneal or conjunctival debris. - Minor eye surgery: supplies pre‑operative anesthesia for procedures such as cataract extraction or laser treatment.

Tetracaine Hydrochloride may cause ocular irritation and, in rare cases, more severe complications.

Common Side Effects: - Burning or stinging sensation - Transient redness of the eye - Temporary blurred vision - Increased tearing

Serious or Rare Side Effects: - Corneal epithelial damage - Allergic reaction with swelling - Severe ocular inflammation

Before using Minims Tetracaine Chlorhydrate, consider the following precautions: - Allergy assessment: confirm no hypersensitivity to tetracaine or related ester anesthetics. - Indication limitation: use only for short‑term ocular anesthesia during diagnostic or minor surgical procedures. - Corneal integrity: avoid application on severely damaged or infected cornea. - Patient monitoring: observe for excessive irritation, visual changes, or systemic signs during and after use. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from light and moisture.

Tetracaine Hydrochloride can interact with other ophthalmic agents and systemic drugs.

Major Interactions (Avoid): - Concurrent use of other ophthalmic local anesthetics: may increase risk of corneal toxicity. - Systemic sodium channel blockers (e.g., quinidine, procainamide): may potentiate cardiac conduction effects.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: may enhance systemic absorption of tetracaine. - Anticholinergic eye drops: could affect pupil response when combined. - Topical corticosteroids: may mask early signs of ocular irritation.